Insulet | 市值



金融业
股票价格
USD
资产
USD 3.19B
现金及等价物
USD 716.1M
销售成本
USD 215.2M
流动资产
USD 1.91B
流动负债
USD 680.1M
债务
USD 1.01B
EBIT
USD 146.3M
EBITDA
USD 194M
员工
3.9K
EPS每股收益
USD 1.44
股本和储备
USD 1.52B
销售毛利
USD 568.6M
债务利息支出
USD 9.2M
利息收入
USD 8.6M
贷款资金
USD 930.8M
市值
USD 17.44B
净收入
USD 101.6M
营业费用
USD 637.5M
营业利润
USD 146.3M
普通股股本
USD 70.35M
PE价格收益
USD 55.08
税前利润
USD 140.2M
销售收入
USD 783.8M
销售和管理费用
USD 331.4M
股票
USD 452.6M
贸易债权人
USD 75M
应收帐款人
USD 516.9M


市值 更改 日
Abbott USD 217.86B 15.25B 2025-12
Align Technology USD 12.04B 838M 2026-02
AtriCure USD 1.61B 360M 2026-02
Avanos Medical USD 700M 179M 2026-02
Baxter International USD 9.54B 279M 2026-02
Becton, Dickinson and Co. USD 51.01B 4.28B 2026-02
Boston Scientific USD 110.32B 31.04B 2026-02
Cardinal Health USD 54.98B 6.15B 2026-02
Cooper Companies USD 13.9B 205M 2025-09
Dexcom USD 25.44B 449M 2026-02
Edwards Lifesciences USD 44.75B 4.72B 2026-02
Eli Lilly USD 1.01T 3.37B 2026-02
Globus Medical USD 12.61B 4.87B 2026-02
ICU Medical USD 3.62B 93M 2026-02
Inogen USD 121M 146M 2023-09
Insulet USD 18.05B 1.95B 2026-02
Integra LifeSciences USD 1.12B 163M 2025-09
J&J USD 500.24B 67.44B 2025-12
Masimo USD 7.68B 1.44B 2025-09
Medtronic USD 118.67B 10.66B 2026-02
Merit Medical Systems USD 4.73B 201M 2026-02
Roche Holding CHF 266.34B 55.46B 2025-12
Stryker USD 134.41B 6.92B 2025-12
Tandem Diabetes Care USD 1.21B 278M 2026-02
Teleflex USD 5.3B 73M 2025-09
West Pharmaceutical Services USD 17.83B 1.96B 2026-02
WK Kellogg Co USD 12.66B 464.02M 2025-09
Zimmer Biomet Holdings USD 19.82B 2B 2026-02


Insulet 市值 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.